Promising aspects and caveats of studies on anti-apoptotic therapies in patients with heart failure

European Journal of Heart Failure

Volumn 9, Issue 2, 2007, Pages 120-123

  Khoynezhad, Ali ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cell signaling; Heart failure; Heart physiology; Myocardial remodeling

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOSIS INDUCING FACTOR; APOPTOSIS INHIBITOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; CASPASE INHIBITOR; CYSTEINE PROTEINASE; FLICE INHIBITORY PROTEIN; GROWTH HORMONE; IDN 6734; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; CONGESTIVE HEART FAILURE; EDITORIAL; HEALTH CARE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; NICK END LABELING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; HEART; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; SIGNAL TRANSDUCTION;

EID: 33847776132     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.12.009     Document Type: Editorial

References (15)

1. Berry C., Murdoch D.R., and McMurray J.J. Economics of chronic heart failure. Eur J Heart Fail 3 3 (Jun 2001) 283-291
2. Kubota T., McTiernan C.F., Frye C.S., et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81 4 (1997) 627-635
3. Khoynezhad A., Jalali Z., and Tortolani A.J. Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon. Ann Thorac Surg 78 (2004) 1109-1118
4. Ibe W, Saraste A, Lindemann S, et al. Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodeling in dilated cardiomyopathy, but is not affected by growth hormone treatment. Eur J Heart Fail in this issue.
5. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med 336 16 (1997) 1131-1141
6. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335 16 (1996) 1182-1189
7. Sharov V.G., Sabbah H.N., Shimoyama H., et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148 (1996) 141-149
8. Yao M., Keogh A., Spratt P., et al. Elevated DNase I levels in human idiopathic dilated cardiomyopathy: an indicator of apoptosis?. J Mol Cell Cardiol 28 (1996) 95-101
9. Saraste A., Pulkki K., Kallajoki M., et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29 5 (1999) 380-386
10. Guerra S., Leri A., Wang X., et al. Myocyte death in the failing human heart is gender dependent. Circ Res 85 9 (1999) 856-866
11. Takemura G., Ohno M., Hayakawa Y., et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82 11 (1998) 1130-1138
12. Hayakawa K., Takemura G., Kanoh M., et al. Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 108 1 (2003) 104-109
13. Yaoita H., Ogawa K., Maehara K., et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97 3 (1998) 276-281
14. Armstrong R.C., Li F., Smiley R., et al. Caspase inhibitors reduce infarct size when dosed post-perfusion in a rodent cardiac ischemia/reperfusion model. Circulation 104 (2001) II-12
15. Parissis J.T., Adamopoulos S., Karatzas D., Paraskevaidis J., Livanis E., and Kremastinos D. Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy. Eur J Cardiovasc Prev Rehabil 12 2 (Apr 2005) 164-168